Home Applications 209077 Application 209077
Type ANDA
Sponsor SAGENT PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION 200MG/5.26ML (38MG/ML) No No 002 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION 1GM/26.3ML (38MG/ML) No No 003 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION 2GM/52.6ML (38MG/ML) No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209077-001 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 A209077-002 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 A209077-003 GEMCITABINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 A209077-003 GEMCITABINE HYDROCHLORIDE 2GM/52.6ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A209077-001 GEMCITABINE HYDROCHLORIDE 200MG/5.26ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 A209077-002 GEMCITABINE HYDROCHLORIDE 1GM/26.3ML (38MG/ML) INJECTABLE / INJECTION AP 2018-07-20 c0c555d07b60…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 132 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 1 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 25021-239 Gemcitabine gemcitabine Sagent Pharmaceuticals ANDA Current